Consolidated results for the 2007 financial year
Turnover up by 10% and net profit rises by 34%
Arseus lays healthy foundation for continued growth
Arseus intends to acquire French company Julie-Owandy
Today Arseus publishes its results for the 2007 financial year in a separate document that you can consult in the appendix to this press release and at www.arseus.com. This report contains the key figures with notes.
Thanks to the successful implementation of the new strategy in 2006, Arseus was launched on the stock exchange in October 2007, earlier than planned. In spite of this time-consuming exercise, the management has been able to continue the positive trend that commenced from the fourth quarter of 2006. The increase of the turnover and the profit is mainly due to the introduction of own new products and innovative concepts.
Besides completing several restructuring processes, especially within Arseus Dental and Arseus Medical, there was further effort invested in the integration of the back office and the logistics.
In this context, an investment programme was started with the goal of streamlining the various computer systems and optimising the logistics processes by implementing a warehouse management system; furthermore a start was also made to bring all servers into a remote data centre, in order to improve their cost efficiency and security.
Due to the complete spin-off of Arseus from Omega Pharma, the corporate structure became further extended. The management is convinced that Arseus has laid a healthy foundation to continue growing, and is sure that the group is also ready to achieve its target of EUR 500 million turnover in 2010, and to realise this by means of a balanced combination of organic and external growth.